Futibatinib - Taiho Oncology/Taiho Pharmaceutical
At a glance
- Drug Originator Taiho Pharmaceutical
- Drug Class Amines; Antineoplastics; Ketones; Phenyl ethers; Pyrazoles; Pyrimidines; Pyrrolidines; Small molecules
- Mechanism of Action Type 1 fibroblast growth factor receptor antagonists; Type 3 fibroblast growth factor receptor antagonists; Type 4 fibroblast growth factor receptor antagonists; Type-2 fibroblast growth factor receptor antagonists
- USA Patent Applicants TAIHO ONCOLOGY
- USA Patents 3
- NDAs 1
- International Patents 77
- Patent Applications 199
Table of Contents

Disclaimer